RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases
Genomics, Proteomics & Bioinformatics · 03.12.2024 · 22 (5)
DOI: 10.1093/gpbjnl/qzae063 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genomics, Proteomics & Bioinformatics, online erschienen am 28.09.2024. Verfasst von Yanfang Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional and Western Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Hauptthemen laut MEDLINE: 5-Methylcytosine, Neoplasms. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
RNA methylation modifications influence gene expression, and disruptions of these processes are often associated with various human diseases. The common RNA methylation modification 5-methylcytosine (m5C), which is dynamically regulated by writers, erasers, and readers, widely occurs in transfer RNAs (tRNAs), messenger RNAs (mRNAs), ribosomal RNAs (rRNAs), enhancer RNAs (eRNAs), and other non-coding RNAs (ncRNAs). RNA m5C modification regulates metabolism, stability, nuclear export, and translation of RNA molecules. An increasing number of studies have revealed the critical roles of the m5C RNA modification and its regulators in the development, diagnosis, prognosis, and treatment of various human diseases. In this review, we summarized the recent studies on RNA m5C modification and discussed the advances in its detection methodologies, distribution, and regulators. Furthermore, we addressed the significance of RNAs modified with m5C marks in essential biological processes as well as in the development of various human disorders, from neurological diseases to cancers. This review provides a new perspective on the diagnosis, treatment, and monitoring of human diseases by elucidating the complex regulatory network of the epigenetic m5C modification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrated Traditional and Western Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Research Institute of Nephrology, Zhengzhou University, Zhengzhou 450052, China.
- Henan Province Research Center for Kidney Disease, Zhengzhou 450052, China.
- Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou 450052, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
ORCID-Profile: Yanfang Lu, Liu Yang, Qi Feng, Yong Liu, Xiaohui Sun, Dongwei Liu, Long Qiao, Zhangsuo Liu
Zitieren
APA
Lu, Y., Yang, L., Feng, Q., Liu, Y., Sun, X., Liu, D., Qiao, L., & Liu, Z. (2024). RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases. Genomics, Proteomics & Bioinformatics, 22(5). https://doi.org/10.1093/gpbjnl/qzae063
Vancouver
Lu Y, Yang L, Feng Q, Liu Y, Sun X, Liu D, et al. RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases. Genomics, Proteomics & Bioinformatics. 2024;22(5). doi:10.1093/gpbjnl/qzae063
BibTeX
@article{Lu2024,
author = {Lu, Yanfang and Yang, Liu and Feng, Qi and Liu, Yong and Sun, Xiaohui and Liu, Dongwei and Qiao, Long and Liu, Zhangsuo},
title = {RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases},
journal = {Genomics, Proteomics & Bioinformatics},
year = {2024},
volume = {22},
number = {5},
doi = {10.1093/gpbjnl/qzae063}
}
EUVIMED